In fact, numerous reports have pointed out that a high TLR9 expression is linked to tumor expansion and metastasis, establishing its identification as a new prognostic biomarker in the context of hematological cancer, although its role in prognosis stratification is not still fully established [37]. The gene discussed is TLR9; the disease is hematopoietic and lymphoid cell neoplasm.